Chang, Jung-Chi
Lin, Hsiang-Yuan
Lv, Jinglei
Tseng, Wen-Yih Issac
Gau, Susan Shur-Fen
Article History
Received: 8 November 2020
Accepted: 24 December 2020
First Online: 11 January 2021
Change Date: 16 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12888-021-03096-3
Ethics approval and consent to participate
: The present study approved by the Research Ethics Committee at NTUH (#200903062R, #201204071RIC, #201401024RINC) and registered with ExternalRef removed (NCT00916851, NCT01682915, NCT02642068). The procedures and the purposes were explained face-to-face to the participants and their parents, who then provided the written informed consent.
: All authors have read and approved the final version of the manuscript for submission.
: SSG and HYL were among the investigators of a clinical trial supported by Orient Pharma Co., Ltd. (OP-2PN012–301), Taiwan. The authors declare no other competing interests related to this work.